Technology
May 29, 2024

Advancement in Ocular Device Technology to Transform Cataract Treatment

This breakthrough could potentially revolutionize the treatment of cataracts and refractive surgeries, offering unprecedented levels of customisation and design precision, which could lead to better clinical outcomes.
Advancement in Ocular Device Technology to Transform Cataract Treatment

The University of East Anglia (UEA) has made significant strides in ocular device technology with the development of a novel resin for 3D printing intraocular devices. This breakthrough could potentially revolutionize the treatment of cataracts and refractive surgeries, offering unprecedented levels of customisation and design precision, which could lead to better clinical outcomes.

Advancements in Ocular Device Technology

Lead author Dr. Aram Saeed, Associate Professor in Healthcare Technologies at UEA's School of Pharmacy, highlighted the potential of this breakthrough, stating, "For the first time, we have developed a resin that can be used to print ocular devices directly." This innovation opens the door to tailored lenses for each patient's eye shape and vision needs, faster production, and more complex designs.

Impact on Eye Care Practices

The use of 3D printing technology in ocular device production could decrease the cost of custom lenses and facilitate the testing and utilization of new materials. The research team's focus on refining and enhancing the technology sets the stage for transforming eye care practices globally. Dr. Saeed emphasized, "As we continue to publish our findings and share our advancements, we aim to be at the forefront of the industry, working with industrial partners and researchers worldwide."

Future Prospects and Clinical Trials

The UEA team's dedication to accuracy on a larger scale and improving printing resolution indicates a clear path towards potential clinical trials in the next few years. The research has already received recognition and funding from various organizations, including a United States patent, UEA's Innovation Development Fund and Proof-Of-Concept grants, the Humane Research Trust, the EPSRC, UEA's Impact Acceleration Account, and the Medical Research Council (MRC).

This breakthrough in ocular device technology not only showcases the potential for growth in the technology sector but also offers hope for improved eye care, demonstrating the positive impact of innovative research and development in healthcare.

Continue Reading